Welcome to Medications.com

Alkermes Provides Update on Inhaled Insulin Program - PharmaLive.com (press release)

Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for ...

http://www.medadnews.com/News/ind... | Posted: Fri Mar 07 10:33:31 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea